Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer

Authors
Publication date
1 January 2020
Publisher
'IOS Press'
Doi

    Abstract

    BACKGROUND: Novel biomarkers are needed to predict the effectiveness of the treatment of presurgical neoadjuvant chemotherapy (NAC) in breast cancer (BC)

      Similar works

      Full text

      thumbnail-image

      Available Versions

      İstanbul Üniversitesi Açık Erişim Sistemi

      redirect
      oaioai:http://acikerisim.istanbul...
      Last time updated on 18/03/2021